• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GT Biopharma, Inc. - Common Stock (NQ: GTBP )

1.745 -0.175 (-9.11%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GT Biopharma, Inc. - Common Stock

< Previous 1 2 3 Next >
GTBP Stock Earnings: GT Biopharma Reported Results for Q2 2024
August 14, 2024
GT Biopharma just reported results for the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 22, 2024
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 21, 2024
Via Benzinga
What's Going On With GT Biopharma Stock Tuesday?
May 21, 2024
GT Biopharma entered into a definitive securities purchase agreement for the purchase and sale of 740,000 shares of its common stock at a purchase price of $4.35 per share. The shares will be offered... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
May 20, 2024
Via Benzinga
Recap: GT Biopharma Q4 Earnings
March 26, 2024
Via Benzinga
What's Going On With GT Biopharma Stock?
May 20, 2024
GT Biopharma shares are moving on heavy trading volume despite a lack of company-specific news. The stock is one of the top trending tickers on Stocktwits which may point to a rally led by retail... 
Via Benzinga
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 20, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 20, 2024
Via Benzinga
US Stocks Mixed; Li Auto Shares Plummet After Q1 Results
May 20, 2024
Via Benzinga
Why Is Jaguar Health (JAGX) Stock Down 40% Today?
May 20, 2024
Jaguar Health stock is down on Monday after the company announced plans for a reverse split of JAGX later this week. 
Via InvestorPlace
Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?
May 20, 2024
Virios Therapeutics stock is down on Monday after the company announced the pricing for a public offering of VIRI shares today. 
Via InvestorPlace
Why Is GT Biopharma (GTBP) Stock Up 143% Today?
May 20, 2024
GT Biopharma stock is up on Monday with heavy trading of GTBP shares despite a lack of news from the biopharmaceutical company. 
Via InvestorPlace
Why Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
May 20, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 20, 2024
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
May 20, 2024
Pre-market stock movers are a great way to start the trading week and we have all of the hottest news worth reading about on Monday! 
Via InvestorPlace
GTBP Stock Earnings: GT Biopharma Beats EPS for Q1 2024
May 16, 2024
GTBP stock results show that GT Biopharma beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 07, 2024
Via Benzinga
GTBP Stock Earnings: GT Biopharma Beats EPS for Q4 2023
March 26, 2024
GTBP stock results show that GT Biopharma beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 22, 2024
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 15, 2023
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 07, 2023
It's time for another dive into the biggest pre-market stock movers as we break down all of the latest news for Tuesday morning. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
August 04, 2023
It's time to start the day final of trading this week with an overview of the biggest pre-market stock movers on Friday morning! 
Via InvestorPlace
Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 14, 2023
Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday. 
Via Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 14, 2023
Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
July 13, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 08, 2023
Via Benzinga
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 06, 2023
Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 12, 2023
Via Benzinga
Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 31, 2023
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of... 
Via Benzinga
< Previous 1 2 3 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap